LEADER 04586nam 2200589Ia 450 001 9910452187603321 005 20200520144314.0 010 $a1-60876-480-X 035 $a(CKB)2550000001041265 035 $a(EBL)3018307 035 $a(SSID)ssj0000834854 035 $a(PQKBManifestationID)11412034 035 $a(PQKBTitleCode)TC0000834854 035 $a(PQKBWorkID)10982142 035 $a(PQKB)11211311 035 $a(MiAaPQ)EBC3018307 035 $a(Au-PeEL)EBL3018307 035 $a(CaPaEBR)ebr10660168 035 $a(OCoLC)923657722 035 $a(EXLCZ)992550000001041265 100 $a20080709d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAIDS vaccines, HIV receptors, and AIDS research$b[electronic resource] /$fLawrence B. Kendow, editor 210 $aNew York $cNova Biomedical Books$dc2008 215 $a1 online resource (358 p.) 300 $aDescription based upon print version of record. 311 $a1-60692-074-X 320 $aIncludes bibliographical references and index. 327 $a""AIDS VACCINES, HIV RECEPTORS, AND AIDS RESEARCH""; ""CONTENTS""; ""PREFACE""; ""Chapter 1 SAFE AND EFFECTIVE HIV VACCINES SINCE 1999 ""; ""ABSTRACT ""; ""INTRODUCTION""; ""SOME PRE-1984 VACCINES FOR HUMAN USE ""; ""Plague ""; ""Variolation ""; ""Edward Jennera???s Smallpox Vaccine""; ""Louis Pasteura???s Vaccines""; ""Polio Vaccines""; ""THE NORMAL HUMAN IMMUNE RESPONSE""; ""THE WORST PANDEMIC IN HISTORY, HIV/AIDS""; ""The First Announcement of the Isolation of the Causative Agent of AIDS ""; ""The Natural History of HIV Infection in Man"" 327 $a""Ethical Considerations in HIV Preventive Vaccine Research """"THE AUTHORa???S APPROACH TO HIV VACCINES DEVELOPMENT""; ""A General Surgeon Involved with HIV Vaccines Research and Development? ""; ""What is Cure of HIV Infection?""; ""The Stepping Stone for HIV Preventive Vaccines Development""; ""Not all Medical Remedies Require Registration before use on Patients""; ""Possible Appropriate Immunogens for a Candidate HIV Therapeutic Vaccine""; ""Confirmation of the Safety of the Candidate Autogenous HIV Therapeutic Vaccine""; ""Efficacy Trials of the Safe Candidate HIV Therapeutic Vaccine"" 327 $a""Proceeding to the HIV Preventive Vaccine """"Modifications to the Initial Vaccines and Dosage Regimen""; ""THE VACCINES ON LARGER POPULATIONS""; ""VEHEMENT RESISTANCE TO ATTEMPTS TO LOCK UP OUR HIV VACCINES""; ""CONCLUSION""; ""APPENDICES""; ""REFERENCES ""; ""Chapter 2 AIDS: A MUCOSAL APPROACH TO A MUCOSAL INFECTION ""; ""ABSTRACT""; ""INTRODUCTION""; ""Mucosal Transmission and HIV Receptors""; ""Correlates of Protection; LTNPs, Elite Controllers and Natural Hosts ""; ""TARGETING THE MUCOSAL IMMUNE SYSTEM""; ""Mucosal Adjuvants ""; ""Innate Immunity and Antiviral Factors "" 327 $a""Early Experiments Revisited a??? Xeno and Allo-Immunity in HIV Protection """"SUMMARY ""; ""REFERENCES""; ""Chapter 3 TRANSMISSION OF HIV FROM DENDRITIC CELLS TO CD4+ T CELLS: A PROMISING TARGET FOR VACCINATION AND THERAPEUTIC INTERVENTION ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""1. Subsets of DCs and Susceptibility to HIV Infection""; ""2. Restriction of HIV-1 Replication in DCs""; ""3. HIV Transmission from DC to T cells: trans vs. cis Infection""; ""4. How to Achieve Immune Protection: Future Directions ""; ""CONCLUSION ""; ""ACKNOWLEDGEMENTS ""; ""REFERENCES "" 327 $a""Chapter 4 THE GLOBALIZATION-AIDS-POVERTY SYNDROME IN AFRICA1 """"INTRODUCTION ""; ""NEOLIBERALIZM AND AIDS IN CONTEXT ""; ""COLONIALISM, GENDER, AND THE GEOGRAPHY OF HIV""; ""THE LIBERALIZATION OF AIDS: GLOBALIZATION AND POVERTY""; ""MAKING THE LINKS: GENDER, DEEPENING POVERTY AND AIDS""; ""BREAKING THE GAPS""; ""REFERENCES ""; ""Chapter 5 YOUTH SEXUALITY IN THE CONTEXT OF HIV/AIDS IN SOUTH AFRICA ""; ""ABSTRACT""; ""1. INTRODUCTION ""; ""Socialization""; ""Sexual Relations""; ""Sexuality Research and HIV""; ""Culture and Sexuality""; ""Sociohistorical Context ""; ""2. METHODOLOGY"" 327 $a""Sample and Procedure"" 606 $aAIDS vaccines 606 $aHIV (Viruses) 608 $aElectronic books. 615 0$aAIDS vaccines. 615 0$aHIV (Viruses) 676 $a615/.372 701 $aKendow$b Lawrence B$0962532 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910452187603321 996 $aAIDS vaccines, HIV receptors, and AIDS research$92182654 997 $aUNINA